2008 - Fellow of the American Psychological Association (APA)
His primary areas of investigation include Pharmacology, Amphetamine, Drug, Psychiatry and Anesthesia. His Pharmacology research is multidisciplinary, incorporating elements of Stimulus control, Triazolam, Ritanserin and Blood pressure. Craig R. Rush interconnects Clinical trial, Bupropion and Sensation seeking, Personality in the investigation of issues within Amphetamine.
Craig R. Rush works mostly in the field of Drug, limiting it down to concerns involving Stimulant and, occasionally, Addiction. His Modafinil study in the realm of Psychiatry connects with subjects such as Benzoylecgonine. His Anesthesia study combines topics in areas such as Oral administration, Acute effects, Randomized controlled trial and Inhibitory control.
The scientist’s investigation covers issues in Pharmacology, Anesthesia, Psychiatry, Amphetamine and Drug. His Pharmacology research is multidisciplinary, incorporating perspectives in Stimulus control and Triazolam. His study focuses on the intersection of Anesthesia and fields such as Pharmacotherapy with connections in the field of Tolerability.
His Amphetamine study combines topics from a wide range of disciplines, such as Adverse effect, Clinical trial, Modafinil and Heart rate. The Drug study which covers Substance abuse that intersects with Attentional bias. His Stimulant study combines topics in areas such as Methylphenidate and Nicotine.
Craig R. Rush mainly focuses on Pharmacology, Self-administration, Attentional bias, Psychiatry and Cocaine users. He combines subjects such as Phendimetrazine, Pharmacotherapy and Naltrexone with his study of Pharmacology. His Self-administration research includes themes of Amphetamine, Blood pressure and Drug.
His Drug research is multidisciplinary, incorporating elements of Cocaine dependence and Clinical psychology. His work on Psychological intervention as part of general Psychiatry research is frequently linked to Socioeconomic status, thereby connecting diverse disciplines of science. His Methamphetamine research is multidisciplinary, relying on both Stimulant and Buspirone.
His primary areas of study are Self-administration, Attentional bias, Pharmacology, Drug and Audiology. His research integrates issues of Psychiatry and Buspirone in his study of Self-administration. Craig R. Rush has included themes like Cognitive psychology and Salience in his Attentional bias study.
His studies deal with areas such as Dextroamphetamine and Naltrexone as well as Pharmacology. The concepts of his Drug study are interwoven with issues in Cocaine use, Substance abuse and Blood plasma. His Audiology research includes elements of Response inhibition, Inhibitory control, Developmental psychology, Eye tracking and Cocaine users.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Impaired inhibitory control of behavior in chronic cocaine users
Mark T Fillmore;Craig R Rush.
Drug and Alcohol Dependence (2002)
Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review.
Scott H Kollins;Emily K MacDonald;Craig R Rush.
Pharmacology, Biochemistry and Behavior (2001)
Individual differences in drug abuse vulnerability: d-Amphetamine and sensation-seeking status
Thomas H. Kelly;Glenn Robbins;Catherine A. Martin;Mark T. Fillmore.
Psychopharmacology (2006)
Acute effects of oral cocaine on inhibitory control of behavior in humans.
Mark T Fillmore;Craig R Rush;Lon Hays.
Drug and Alcohol Dependence (2002)
Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.
Scott H. Kollins;Craig R. Rush;Peggy J. Pazzaglia;Jeffrey A. Ali.
Experimental and Clinical Psychopharmacology (1998)
Acute effects of cocaine in two models of inhibitory control: implications of non‐linear dose effects
Mark T. Fillmore;Craig R. Rush;Lon Hays.
Addiction (2006)
Behavioral Pharmacology of Zolpidem Relative to Benzodiazepines: A Review
Craig R. Rush.
Pharmacology, Biochemistry and Behavior (1998)
Validation of the Multiple-Choice procedure for investigating drug reinforcement in humans
Roland R. Griffiths;Craig R. Rush;Craig R. Rush;Kimberly A. Puhala.
Experimental and Clinical Psychopharmacology (1996)
Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
Craig R. Rush;Scott H. Kollins;Peggy J. Pazzaglia.
Experimental and Clinical Psychopharmacology (1998)
Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans.
Craig R. Rush;William D. Essman;Cathy A. Simpson;Robert W. Baker.
Journal of Clinical Psychopharmacology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Kentucky
University of Vermont
Virginia Tech
University of Vermont
Johns Hopkins University School of Medicine
Duke University
University of Kentucky
Washington State University Spokane
University of Kentucky
The University of Texas Health Science Center at Houston
University of Michigan–Ann Arbor
Stanford University
Royal Institute of Technology
Florida International University
Inserm : Institut national de la santé et de la recherche médicale
Université de Sherbrooke
University of Alberta
National Oceanic and Atmospheric Administration
National University of Singapore
Mayo Clinic
University of California, San Francisco
Universidade Federal de Minas Gerais
University of Queensland
Lancaster University
University of Tokyo
University of Helsinki